75327003: Xylometazoline hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Adrenergic receptor agonist\Alpha adrenergic receptor agonist\Xylometazoline hydrochloride

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Sympathomimetic agent (substance)\Adrenergic receptor agonist\Alpha adrenergic receptor agonist\Xylometazoline hydrochloride
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Respiratory system agent (substance)\Cough AND/OR decongestant agent (substance)\Decongestant (substance)\Xylometazoline hydrochloride

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Imidazole\Xylometazoline hydrochloride

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Imidazole\Xylometazoline hydrochloride
\Organic compound\Organic nitrogen compound\Azole\Imidazole\Xylometazoline hydrochloride

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

125106015 Xylometazoline hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

815924014 Xylometazoline hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

850021000172110 chlorhydrate de xylométazoline fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Xylometazoline hydrochloride	Is a	Product containing xylometazoline (medicinal product)	false	Inferred relationship	Some
Xylometazoline hydrochloride	Is a	Xylometazoline (substance)	false	Inferred relationship	Some
Xylometazoline hydrochloride	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha adrenergic receptor agonist (disposition)	true	Inferred relationship	Some
Xylometazoline hydrochloride	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Xylometazoline (substance)	true	Inferred relationship	Some
Xylometazoline hydrochloride	Is a	Imidazole	true	Inferred relationship	Some
Xylometazoline hydrochloride	Is a	Alpha adrenergic receptor agonist	true	Inferred relationship	Some
Xylometazoline hydrochloride	Is a	Decongestant (substance)	true	Inferred relationship	Some
Xylometazoline hydrochloride	Is a	vasoconstricteur	false	Inferred relationship	Some
Xylometazoline hydrochloride	Is a	Adrenergic receptor agonist	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug)	Is a	False	Xylometazoline hydrochloride	Inferred relationship	Some
Xylometazoline hydrochloride 0.05% pediatric nasal drops	Is a	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal spray (clinical drug)	Is a	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Xylometazoline hydrochloride 0.05% pediatric nasal drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Xylometazoline hydrochloride 0.05% nasal spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Sodium cromoglycate+xylometazoline hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Antazoline sulfate+xylometazoline hydrochloride	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing antazoline and xylometazoline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some
Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 344.48 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal spray (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal spray (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Xylometazoline hydrochloride	Inferred relationship	Some	2
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Xylometazoline hydrochloride	Inferred relationship	Some	2
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release solution for nasal drops	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release solution for nasal drops	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release nasal drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely xylometazoline hydrochloride 500 microgram/1 milliliter conventional release nasal drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Xylometazoline hydrochloride	Inferred relationship	Some	2
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Xylometazoline hydrochloride	Inferred relationship	Some	2
Xylometazoline hydrochloride 140 microgram/actuation nasal spray	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Xylometazoline hydrochloride	Inferred relationship	Some	1
Xylometazoline hydrochloride 140 microgram/actuation nasal spray	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Xylometazoline hydrochloride	Inferred relationship	Some	1

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
125106015	Xylometazoline hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
815924014	Xylometazoline hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
850021000172110	chlorhydrate de xylométazoline	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module